RE:Seems #1 like the Euphas2 registry was split into 2 piecesSeem V is immensely lacking. It has been 5 months since the company told us they " are currently undergoing an interactive dialogue with the US Food and Drug Administration (the FDA”) aimed at the collection of more information regarding safety and efficacy for the PMX cartridge as a part of the FDA approval process. The goal is to add more information to data already obtained in the EUPHRATES trial. In the EUPHRATES trial, a specific group of patients showed a 40% reduction in relative risk for death at 28-days."
How many patients with sepsis have died since? Isn't time of the essence?